Moreover, they are potent and selective iNOS inhibitors (IC50 = 0.075 and 0.098 μM, respectively), and they were potential antiproliferative agents against the MCF-7 breast cancer cell line (IC50 = 25 and 28 nM, respectively). Here, NOS2 is linked to breast carcinoma.